https://investinlife.com/2017/03/08/news/2017-03-08T20:05:43+00:00https://investinlife.com/2017/03/14/lloyd-j-old-m-d-chairman-emeritus/2017-03-14T20:38:34+00:00https://investinlife.com/2017/03/14/pramod-srivastava-ph-d-m-d-member-board-of-directors/2017-03-14T20:38:28+00:00https://investinlife.com/2017/03/14/richard-van-steen-vice-president-and-member-board-of-directors/2017-03-14T20:38:22+00:00https://investinlife.com/2017/03/14/james-fiore-president-ceo-and-member-board-of-directors/2017-03-14T20:38:16+00:00https://investinlife.com/2017/03/14/about-abt-414806/2017-03-14T20:50:49+00:00https://investinlife.com/2017/03/14/life-science-pharmaceuticals-announces-initiation-of-phase-1-clinical-trial-of-abt-806-for-the-treatment-of-cancer/2017-03-14T21:11:57+00:00https://investinlife.com/2017/03/14/life-science-pharmaceuticals-enters-into-agreement-with-abbott-to-develop-antibody-806/2017-03-14T21:12:20+00:00https://investinlife.com/2017/03/14/kyowa-hakko-kogyo-co-ltd-grants-life-science-pharmaceuticals-inc-a-world-wide-license-to-develop-and-market-monoclonal-antibody-targeting-melanoma/2017-03-14T21:12:44+00:00